Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel
Light transmission aggregometry (LTA) is used worldwide for the investigation of
Guideline on the investigation and management of acute transfusion reactions Prepared by the BCSH Blood Transfusion Task Force
11:31
סגור לתגובות על Guideline on the investigation and management of acute transfusion reactions Prepared by the BCSH Blood Transfusion Task Force
Although acute non-haemolytic febrile or allergic reactions (ATRs) are a common complication of transfusion and often result in little or
How I treat anticoagulated patients undergoing an elective procedure or surgery
10:49
סגור לתגובות על How I treat anticoagulated patients undergoing an elective procedure or surgery
The periprocedural management of patients receiving long-term oral anticoagulant therapy remains
How I treat transfusional iron overload
12:17
סגור לתגובות על How I treat transfusional iron overload
Patients with ?-thalassemia major (TM) and other refractory anemias requiring regular
How I treat relapsed childhood acute lymphoblastic leukemia
12:31
סגור לתגובות על How I treat relapsed childhood acute lymphoblastic leukemia
The most common cause of treatment failure in childhood acute lymphoblastic
Guidelines on the investigation and management of venous thrombosis at unusual sites
17:21
סגור לתגובות על Guidelines on the investigation and management of venous thrombosis at unusual sites
Deep vein thrombosis (DVT) of the lower limb veins and pulmonary embolism (PE) are the most commonly encountered manifestations
How I treat relapsed childhood acute lymphoblastic leukemia
14:44
סגור לתגובות על How I treat relapsed childhood acute lymphoblastic leukemia
Franco Locatelli, Martin Schrappe, Maria Ester Bernardo and Sergio Rutella
Blood 2012 :blood-2012-02-265884
AREN0534 – Treatment for Patients with Bilateral, Multicentric, or Bilaterally-Predisposed Unilateral Wilms Tumor
10:24
אין תגובות
A Groupwide Phase III Study
High Risk Neuroblastoma Study 1.5 of SIOP-Europe – SIOPEN
11:09
סגור לתגובות על High Risk Neuroblastoma Study 1.5 of SIOP-Europe – SIOPEN
מצגת
